Search results for "Pharmacy"

showing 10 items of 705 documents

Metabolic detoxification: implications for thresholds.

2000

The fact that chemical carcinogenesis involves single, isolated, essentially irreversible molecular events as discrete steps, several of which must occur in a row to finally culminate in the development of a malignancy, rather suggests that an absolute threshold for chemical carcinogens may not exist. However, practical thresholds may exist due to saturable pathways involved in the metabolic processing, especially in the metabolic inactivation, of such compounds. An important example for such a pathway is the enzymatic hydrolysis of epoxides via epoxide hydrolases, a group of enzymes for which the catalytic mechanism has recently been established. These enzymes convert their substrates via…

040301 veterinary sciencesDNA damageEpoxide10050 Institute of Pharmacology and Toxicology610 Medicine & healthToxicology030226 pharmacology & pharmacyPathology and Forensic MedicineXenobiotics0403 veterinary science1307 Cell Biology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEnzymatic hydrolysis1312 Molecular BiologyAnimalsHumansComputer SimulationEpoxide hydrolaseMolecular BiologyCarcinogenchemistry.chemical_classificationEpoxide HydrolasesDose-Response Relationship Drug3005 Toxicology04 agricultural and veterinary sciencesCell Biology2734 Pathology and Forensic MedicineEnzymechemistryBiochemistryCovalent bondEpoxide HydrolasesInactivation MetabolicCarcinogensMicrosomes Liver570 Life sciences; biologyMutagensToxicologic pathology
researchProduct

Resistance to water and abrasion of a broad-spectrum sunscreen: a prospective, open-label study.

2015

1303 BiochemistryFrictionAbrasion (mechanical)Ultraviolet RaysDrug Evaluation PreclinicalSunburn610 Medicine & healthSunscreening AgentsDermatologyAdministration Cutaneous030226 pharmacology & pharmacyBiochemistry2708 Dermatology03 medical and health sciencesBroad spectrum0404 agricultural biotechnology0302 clinical medicineOpen label study1312 Molecular BiologymedicineHumansProspective StudiesSunburnComposite materialMolecular BiologySkin damageSkinWater resistanceChemistry10177 Dermatology ClinicWater04 agricultural and veterinary sciencesmedicine.disease040401 food scienceLiposomesHydrophobic and Hydrophilic InteractionsSunscreening AgentsExperimental dermatology
researchProduct

Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?

2020

The authors would like to thank Agnieszka Michalczuk for providing us with her artistic vision of SARS-CoV-2.

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:Medicinelcsh:RS1-441Pharmaceutical Sciencechemistry.chemical_elementZincReviewlcsh:Pharmacy and materia medicachloroquine03 medical and health scienceschemistry.chemical_compoundChloroquineRNA polymeraseDrug Discoverymedicine030304 developmental biology0303 health sciences030306 microbiologybusiness.industrySARS-CoV-2lcsh:RCOVID-19HydroxychloroquineChloroquinehydroxy- chloroquineVirologychemistry2019-nCoVMolecular MedicinebusinessZn(II) ionophoresmedicine.drugHydroxychloroquinePharmaceuticals
researchProduct

Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA

2021

Several lines of evidence attest that the ongoing coronavirus disease 2019 (COVID-19) pandemic is accompanied by a vast array of physiological problems in the community.1 Since the emergence or magnification of anxiety disorders in the general population has also been suggested during the COVID-19 outbreak,2 we aimed to provide further insights on this matter by performing an electronic search in Google Trends (Google Inc, Mountain View, CA, USA), using the terms corresponding to the most common anxiolytic medicines used in the USA (ie, ‘Alprazolam’, ‘Diazepam’, ‘Lorazepam’, and ‘Clonazepam’) along with their brand names (‘Xanax’, ‘Valium’, ‘Ativan’, and ‘Klonopin’, respectively), and setti…

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Population030226 pharmacology & pharmacyDisease Outbreaks03 medical and health sciencessocial medicine0302 clinical medicinePandemicHumansMedicine030212 general & internal medicineGeneral Pharmacology Toxicology and Pharmaceuticseducationeducation.field_of_studyBrand namesSARS-CoV-2business.industryPublic healthpublic healthOutbreakCOVID-19Anxiolytic drugsUnited Statesprimary health careAnti-Anxiety AgentsCOVID-19 mental health primary health care public health social medicinebusinessmental healthDemography
researchProduct

The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic

2021

Objective To create an informatics supportive tool, which can assist healthcare professionals in estimating potential requirements for essential drug supplies to respond to the current SARS-CoV-2 pandemic based on epidemiological forecasting. Methods The tool was based on a Susceptible-Infected-Removed (SIR) epidemiological model in which the population is divided into three compartments and transmission parameters are specified to define the rate at which people move between stages. Appropriate data entry was guaranteed by the creation of structured guided paths. The drugs needed for the forecasted patients were estimated according to a list of critical care drugs compiled by consulting pr…

2474Critical CareComputer sciencePopulationPsychological intervention030226 pharmacology & pharmacyHealth informaticsHealth care rationing03 medical and health sciences0302 clinical medicinePandemicmedicineHumans030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticseducationPandemicsOriginal ResearchEstimationeducation.field_of_studyhealth care rationingSARS-CoV-2business.industrypractice guidelinepublic healthCOVID-19CLINICAL MEDICINEmedicine.disease2341Hospitalizationhealth care economics and organizationsWorkflowInformaticsMedical emergencybusinessMedical InformaticsEuropean Journal of Hospital Pharmacy
researchProduct

Salmeterol Xinafoate (SX) loaded into mucoadhesive solid lipid microparticles for COPD treatment

2019

Chronic obstructive pulmonary disease (COPD) is one of the main health problems worldwide. It is characterised by chronic inflammation in the lungs that leads to progressive, chronic, largely irreversible airflow obstruction. The use of long-acting β agonists remain today the frontline treatment for COPD with the aim of minimizing side effects and enhancing therapeutic usefulness. To this purpose, in this paper, mucoadhesive solid lipid microparticles (SLMs) containing a long-acting β-2 agonist, Salmeterol Xinafoate (SX) were prepared, characterised (size, z-potential, aerodynamic diameter, turbidimetric evaluations, drug loading and entrapping efficiency) and tested in a model of bronchial…

3003AgonistDrugAlginatesCell Survivalmedicine.drug_classmedia_common.quotation_subjectSodium alginate polymerPharmaceutical ScienceChronic obstructive pulmonary disease (COPD)Inflammation02 engineering and technologyPharmacology030226 pharmacology & pharmacyCell LinePulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicinecAMPmedicineHumansAerodynamic diameterAdrenergic beta-2 Receptor AgonistsSalmeterol Xinafoatemedia_commonDrug CarriersCOPDInhalationChemistryTherapeutic effectAdhesiveness021001 nanoscience & nanotechnologymedicine.diseaseLipidsSALMETEROL XINAFOATEBronchodilator Agentsrespiratory tract diseasesSalmeterol Xinafoate (SX)MucusAerodynamic diametermedicine.symptom0210 nano-technologyInternational Journal of Pharmaceutics
researchProduct

Co-Loading of Ascorbic Acid and Tocopherol in Eudragit-Nutriosomes to Counteract Intestinal Oxidative Stress

2019

The present study aimed at developing a new vesicular formulation capable of promoting the protective effect of ascorbic acid and tocopherol against intestinal oxidative stress damage, and their efficacy in intestinal wound healing upon oral administration. A pH-dependent copolymer (Eudragit&reg

3003AntioxidantVitamina CVitamina Emedicine.medical_treatmentNeuroimmunologyPhospholipidPharmaceutical Sciencelcsh:RS1-441CicatritzacióWound healingNutriose02 engineering and technologymedicine.disease_causeEudragitArticlelcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compoundOral administrationmedicinePhospholipid vesiclesVitamin ETocopherolVitamin C030304 developmental biology0303 health sciencesIntestinsChromatographyVesiclePrebiotic021001 nanoscience & nanotechnologyAscorbic acidIntestinal wound healingNeuroimmunologiaIntestineschemistryAntioxidant; Eudragit; Intestinal wound healing; Nutriose; Phospholipid vesicles; 3003Antioxidant0210 nano-technologyOxidative stress
researchProduct

Glycerosomes: Use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration.

2016

In this work, diclofenac was encapsulated, as sodium salt, in glycerosomes containing 10, 20 or 30% of glycerol in the water phase with the aim to ameliorate its topical efficacy. Taking into account previous findings, glycerosome formulation was modified, in terms of economic suitability, using a cheap and commercially available mixture of hydrogenated soy phosphatidylcholine (P90H). P90H glycerosomes were spherical and multilamellar; photon correlation spectroscopy showed that obtained vesicles were ∼131nm, slightly larger and more polydispersed than those made with dipalmitoylphosphatidylcholine (DPPC) but, surprisingly, they were able to ameliorate the local delivery of diclofenac, whic…

3003GlycerolKeratinocytesDiclofenacSwineSkin Absorptionpig skinPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyDSC03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDiclofenacDrug Delivery SystemsOrgan Culture TechniquesDynamic light scatteringPhosphatidylcholinemedicineGlycerolAnimalsHumansCells CulturedChromatographyhydrogenated phospholipid vesiclesChemistryVesicle(trans)dermal drug delivery; DSC; hydrogenated phospholipid vesicles; keratinocytes; pig skin; rheology; 3003021001 nanoscience & nanotechnology(trans)dermal drug deliveryDipalmitoylphosphatidylcholineSkin penetrationDrug deliveryPhosphatidylcholinesrheologyHydrogenationSoybeans0210 nano-technologymedicine.drugInternational journal of pharmaceutics
researchProduct

Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: A case study using olanzapine

2016

In this study, we evaluate the dissolution rate enhancement of solid microcrystalline dispersion (SMD) films of olanzapine (OLZ) formulated with four water-soluble polymers namely poly(N-vinylpyrrolidone) (PVP), poloxamer 188 (P188), poloxamer 407 (P407) and Soluplus(®) (SLP). Prepared formulations were characterised to determine particle size, morphology, hydrogen bonding interactions, thermal characteristics as well as in vitro dissolution studies conducted under sink conditions (pH 6.8). Particle size of OLZ in all formulations ranged between 42 and 58μm. Attenuated Total Reflectance Fourier Transform Infrared spectroscopy (ATR-FTIR), Differential Scanning Calorimetry (DSC) and Hot-Stage…

3003PVPDrug CompoundingSolid microcrystalline dispersionPharmaceutical SciencePoloxamer02 engineering and technologyPolyethylene Glycol030226 pharmacology & pharmacyPolyethylene GlycolsBenzodiazepines03 medical and health sciences0302 clinical medicineDifferential scanning calorimetrymedicineParticle SizePyrrolidinoneSolubilityFourier transform infrared spectroscopyPolymerPolyvinylDissolutionPharmaceutical filmBenzodiazepineChromatographyCrystallineChemistryHydrogen BondingPoloxamer021001 nanoscience & nanotechnologyPyrrolidinonesDrug LiberationMicrocrystallineSolubilityChemical engineeringOlanzapinePoloxamer 407PolyvinylsParticle sizeCrystallization0210 nano-technologymedicine.drugInternational Journal of Pharmaceutics
researchProduct

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?

2018

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in Western countries, accounting for 20–30% of general population and reaching a prevalence of 55% in patients with type 2 diabetes mellitus (T2DM). Insulin resistance plays a key role in pathogenic mechanisms of NAFLD. Many drugs have been tested but no medications have yet been approved. Antidiabetic drugs could have a role in the progression reduction of the disease. The aim of this review is to summarize evidence on efficacy and safety of antidiabetic drugs in patients with NAFLD. Metformin, a biguanide, is the most frequently used drug in the treatment of T2DM. To date 15 randomized controlled t…

3003medicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentlcsh:Medicinelcsh:RS1-441Pharmaceutical Sciencehepatic cirrhosis030209 endocrinology & metabolismReviewChronic liver diseaseGastroenterologylcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineInsulin resistanceInternal medicineDiabetes mellitusDrug DiscoverymedicineBiguanidebusiness.industryLiraglutideInsulinlcsh:RFatty liverThiazolidinedionenutritional and metabolic diseasesnon-alcoholic fatty liver diseaseLiraglutidemedicine.diseaseMetforminMetforminHepatic cirrhosiMolecular Medicine030211 gastroenterology & hepatologyThiazolidinedionesnon-alcoholic steatohepatitisbusinessNon-alcoholic steatohepatitimedicine.drugPharmaceuticals (Basel, Switzerland)
researchProduct